SMLR vs. ELMD, OM, EDAP, FONR, VANI, AXGN, HYPR, ZYXI, ABOS, and IPHA
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Electromed (ELMD), Outset Medical (OM), Edap Tms (EDAP), FONAR (FONR), Vivani Medical (VANI), AxoGen (AXGN), Hyperfine (HYPR), Zynex (ZYXI), Acumen Pharmaceuticals (ABOS), and Innate Pharma (IPHA). These companies are all part of the "medical" sector.
Semler Scientific (NASDAQ:SMLR) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment.
In the previous week, Semler Scientific had 1 more articles in the media than Electromed. MarketBeat recorded 4 mentions for Semler Scientific and 3 mentions for Electromed. Semler Scientific's average media sentiment score of 1.04 beat Electromed's score of 0.33 indicating that Semler Scientific is being referred to more favorably in the media.
Semler Scientific has a net margin of 30.19% compared to Electromed's net margin of 7.62%. Semler Scientific's return on equity of 30.60% beat Electromed's return on equity.
Semler Scientific has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.
Electromed received 12 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 85.71% of users gave Electromed an outperform vote while only 0.00% of users gave Semler Scientific an outperform vote.
49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 13.0% of Semler Scientific shares are owned by insiders. Comparatively, 12.7% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Semler Scientific has higher revenue and earnings than Electromed. Semler Scientific is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Summary
Semler Scientific beats Electromed on 12 of the 15 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
